Stoppa-Lyonnet D - Search Results

1

Safety of the Breast Cancer Adjuvant Radiotherapy in Ataxia-Telangiectasia Mutated Variant Carriers.

Bensenane R, Beddok A, Lesueur F, Fourquet A, Warcoin M, Le Mentec M, Cavaciuti E, Le Gal D, Eon-Marchais S, Andrieu N, Stoppa-Lyonnet D, Kirova Y. Bensenane R, et al. Among authors: stoppa lyonnet d. Cancers (Basel). 2024 Apr 5;16(7):1417. doi: 10.3390/cancers16071417. Cancers (Basel). 2024. PMID: 38611095 Free PMC article.

2

Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families.

Janin N, Andrieu N, Ossian K, Laugé A, Croquette MF, Griscelli C, Debré M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D. Janin N, et al. Br J Cancer. 1999 Jun;80(7):1042-5. doi: 10.1038/sj.bjc.6690460. Br J Cancer. 1999. PMID: 10362113 Free PMC article.

3

Low expression of bcl-2 in Brca1-associated breast cancers.

Freneaux P, Stoppa-Lyonnet D, Mouret E, Kambouchner M, Nicolas A, Zafrani B, Vincent-Salomon A, Fourquet A, Magdelenat H, Sastre-Garau X. Freneaux P, et al. Br J Cancer. 2000 Nov;83(10):1318-22. doi: 10.1054/bjoc.2000.1438. Br J Cancer. 2000. PMID: 11044356 Free PMC article.

4

Familial invasive breast cancers: worse outcome related to BRCA1 mutations.

Stoppa-Lyonnet D, Ansquer Y, Dreyfus H, Gautier C, Gauthier-Villars M, Bourstyn E, Clough KB, Magdelénat H, Pouillart P, Vincent-Salomon A, Fourquet A, Asselain B. Stoppa-Lyonnet D, et al. J Clin Oncol. 2000 Dec 15;18(24):4053-9. doi: 10.1200/JCO.2000.18.24.4053. J Clin Oncol. 2000. PMID: 11118466

5

Cancer risk in heterozygotes for ataxia-telangiectasia.

Geoffroy-Perez B, Janin N, Ossian K, Laugé A, Croquette MF, Griscelli C, Debré M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D, Andrieu N. Geoffroy-Perez B, et al. Int J Cancer. 2001 Jul 15;93(2):288-93. doi: 10.1002/ijc.1329. Int J Cancer. 2001. PMID: 11410879 Free article.

6

Variation in breast cancer risk of heterozygotes for ataxia-telangiectasia according to environmental factors.

Geoffroy-Perez B, Janin N, Ossian K, Laugé A, Stoppa-Lyonnet D, Andrieu N. Geoffroy-Perez B, et al. Int J Cancer. 2002 Jun 1;99(4):619-23. doi: 10.1002/ijc.10367. Int J Cancer. 2002. PMID: 11992555 Free article.

7

Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families.

Cavaciuti E, Laugé A, Janin N, Ossian K, Hall J, Stoppa-Lyonnet D, Andrieu N. Cavaciuti E, et al. Genes Chromosomes Cancer. 2005 Jan;42(1):1-9. doi: 10.1002/gcc.20101. Genes Chromosomes Cancer. 2005. PMID: 15390180

8

Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.

Kirova YM, Stoppa-Lyonnet D, Savignoni A, Sigal-Zafrani B, Fabre N, Fourquet A; Institut Curie Breast Cancer Study Group. Kirova YM, et al. Eur J Cancer. 2005 Oct;41(15):2304-11. doi: 10.1016/j.ejca.2005.02.037. Epub 2005 Sep 1. Eur J Cancer. 2005. PMID: 16140006

9

Ataxia-telangiectasia genes and breast cancer risk in a French family study.

Andrieu N, Cavaciuti E, Laugé A, Ossian K, Janin N, Hall J, Stoppa-Lyonnet D. Andrieu N, et al. J Dairy Res. 2005;72 Spec No:73-80. doi: 10.1017/s0022029905001147. J Dairy Res. 2005. PMID: 16180724

10

Increased risk of breast cancer among female relatives of patients with ataxia-telangiectasia: a causal relationship?

d'Almeida AK, Cavaciuti E, Dondon MG, Laugé A, Janin N, Stoppa-Lyonnet D, Andrieu N. d'Almeida AK, et al. Br J Cancer. 2005 Sep 19;93(6):730-2; author reply 732. doi: 10.1038/sj.bjc.6602786. Br J Cancer. 2005. PMID: 16222317 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

488 results

Search Page